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Chronic endometritis is an inflammation in the inner layer of uterine mucosa, with or
without an infectious process, which affects the animal’s fertility but not its general
health. A variety of treatments has been adopted over the years but to date, no
effective cures have been able to renew the injured tissue. Since the defects in the
fetal-maternal communication are caused by degenerative changes due to chronic
endometrial inflammation, our working hypothesis was a new approach to this disease
by the regenerative medicine using amniotic derived microvesicles (MVs) for their
anti-inflammatory and regenerative effects. The MVs are responsible for horizontal
transfer of genetic materials, including microRNA (miRNAs) that are involved in paracrine
communication between origin cells and target cells. Thus, intrauterine MV infusion
may be beneficial in degenerative chronic endometritis and in the fetal–maternal talk.
The selected mare was an 11-year-old Friesian, with a history of failed pregnancies
despite numerous insemination attempts. Punctual and evident heats characterized the
reproductive history, but no insemination attempts had been made for many years.
The first (failed) insemination was when the mare was 9-years-old. In the next two
reproductive seasons, other attempts were made at regular intervals but none was
successful. After a final insemination attempt using a stallion of proven fertility, the
collection of an 8-day old embryo suggested that the mare was affected by implantation
failure related to endometritis. The mare was treated with two cycles of intrauterine
administration of amniotic-derived MVs. The success of the intrauterine administration
of MVs was demonstrated by an improvement in the classification of endometritis and
in a successful artificial insemination (AI) with implantation of an embryo, as detected at
day 14 and with a pregnancy that is still ongoing. Probably, MVs were able to restore
the injured endometrium and re-establish the proper communication for a successful
embryo implantation.
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INTRODUCTION
Fetal-maternal communication is an essential requirement
for the recognition and maintenance of pregnancy. Early
embryo loss during the pre-implantation phase is common
in mammalian species and the pre-implantation phase is a
particularly difficult stage in mares (1, 2). The communication
between uterus and conceptus, essential for adhesion and
implantation, occurs via paracrine signaling. Defects in the
endometrial tissue could hinder this passage of information
and lead to reduced fertility (3). Endometrial inflammations
represent one of the causes of reproductive failure in the
mare. The main consequence of endometritis is a uterine
environment that is hostile for embryo survival and implantation,
causing embryo death and abortion (6). Often, endometritis
is due to infection by sexually or non-sexually transmitted
pathogens, but in a subpopulation of susceptible mares a
particular persistent mating induced endometritis (PMIE) also
occurs (6). Chronic endometritis is an inflammation in the inner
layer of uterine mucosa, with or without an infectious process,
which affects the animal’s fertility but not its general health.
Chronic endometritis could develop because of unresolved PMIE
or as a result of reduced intrinsic uterine defenses, leading
to uncontrolled proliferation of resident microflora causing
persistent inflammation (7). Chronic endometritis is one of
the most frequent causes of infertility, early embryo death,
and embryo death in broodmares (4, 5). Another chronic
degenerative condition of multifactorial origin, such as age
related changes to vascularity and tissue, vascular elastosis, tissue
hypoxia, alterations in tissue remodeling, is called endometrosis
(8). A variety of treatments have been adopted over the years,
most of which are based on empirical practice and are frequently
controversial (9).
Despite the wide range of therapies proposed, their efficacy
has been called into question over the heterogeneity of responses
(10, 11) and, to date, no effective treatments have been able
to renew the injured tissue or to stop this process. Recently,
stem cell treatment has been proposed as an alternative therapy
of uterine disease (12, 12–14, 14, 15). Since the uterine
glandular secretion is considered essential for fetal–maternal
communication and embryo implantation, this report proposes a
novel therapeutic approach based on endometrium regeneration
and on restoration of paracrine fetal–maternal talk by the
use of amniotic-derived MVs that represent the mechanism of
paracrine action of mesenchymal cells.
CASE DETAILS
Signalment, History, and Clinical Findings
The selected mare was an 11-year-old Friesian, with a history
of failed pregnancies despite numerous insemination attempts.
The owner reported that the animal was used for riding
and competition in the past but had recently been turned
out to pasture. No previous pathologies were reported. The
Abbreviations: AI: artificial insemination; AMCs: amniotic mesenchymal cells;
AMC-MVs: MVs obtained from AMC; MVs: microvesicles; miRNA: microRNA;
MSCs: mesenchymal stromal cells; MVs: microvesicles; PMIE: persistent mating
induced endometritis.
reproductive history was characterized by punctual and evident
heats, but no insemination attempts had been made for many
years. The first (failed) insemination was when the mare
was 9-years-old. In the next two reproductive seasons, eight
other attempts (four times in each season) both naturally and
artificially were made but none was successful. Gynecological
examination and instrumental investigations were normal and
there was no relevant history. Visual examination of external
genitalia focused on the perineal conformation to assess the
level between the anus and vulva, paying attention to previous
lacerations or Caslick interventions. In addition, a manual
check of the integrity of the vestibular-vaginal sphincter was
performed to exclude secondary infections due to pneumovagina
or fecal contamination. The inspection of vagina and cervix was
performed with a sterile tubular speculum to detect alterations,
such as purulent drainage, cervical lesions, or urine stagnation
that might indicate endometritis. The vestibule-vaginal features
were also observed to detect the stage of the estrus cycle.
A slight increase in tone and consistency of the uterus and,
particularly of the cervix was detected. Lastly, endometrium
biopsies were performed with a pair of 60 cm alligator forceps,
taking a sample from the dorsal wall of the uterine body. The
aim of the biopsy was to assess the starting condition of the
mare and the results revealed a degenerative chronic category
IIB endometritis. The histological sample showed a continuous
endometrial epithelium composed of columnar cells sometimes
raised in folds. Infiltration of lymphocytes and plasma cells
was observed in the stratum compactum and spongiosum
(Figure 1A) and as periglandular inflammatory clusters
(Figure 1B). Inflammatory cells were accompained with diffuse
edema and mild dilation of lymphatic vessels. Endometrial
glands were mildly reduced in number with accumulation of
eosinophilic secretion and some fibrotic glandular nests were also
observed (Figure 1C).
To support the assumption that the failed inseminations
were related to the pre-implantation phase and to exclude
issues with conception, an insemination test (ninth attempt of
insemination) was performed with the cryopreserved semen
of a stallion of proven fertility. The collection of an 8-
day old embryo confirmed that the issue was due to an
inadequate fetal–maternal communication that would hinder a
successful implantation.
TREATMENT AND OUTCOME
The therapeutic protocol proposed to treat this case was
the intrauterine administration of MVs obtained by in vitro
cultured of amniotic derived cells (AMCs). This protocol was
approved by the Ethical Committee of the University of Milan
(OPBA_118_2017). The AMCs were obtained at birth from
the allanto-amniotic membrane of three broodmares. Samples
were transported at 4◦C in NaCl 0.9% solution supplemented
with 4 mg/mL di amphotericin B (Euroclone), 100 UI/mL
di penicillin, 100 mg/mL di streptomycin (Euroclone), and
handled in laboratory within 12 h. The isolation method was
previously described by Lange Consiglio et al. (16). Microvesicles
isolation was performed following the protocol described by
Perrini et al. (17).
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FIGURE 1 | Histological results of pre-treatment biopsy. They show a category IIB endometritis. (A) Lymphocytes and plasma cells in the stratum compactum and
spongiosum; (B) periglandular inflammatory clusters; (C) fibrotic glandular nests.
FIGURE 2 | Schematic of treatment protocol.
FIGURE 3 | Histological results of biopsy after the first MV administration. An improvement to category IIA endometritis is showed. (A) Slight hemorrhage and edema
in the stratum spongiosum with minimal inflammatory infiltration; (B) quantitatively regular glandular component with occasional fibrotic glandular nests (arrows).
The MV administration protocol was developed in our
Reproduction laboratory and the schematic is shown in Figure 2.
The protocol started on the ovulation day (day 0), which was
detected by trans-rectal ultrasound and clinical examination. The
first treatment was performed on day 5 with an intrauterine
administration of 20 billion MVs diluted in 50ml of NaCl 0.9%.
A second administration was made on day 9. Thereafter, the
mare was monitored every 48 h with ultrasound to detect the
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first and the second post-treatment ovulation. On the 10th day
after the second post-treatment ovulation, during diestrum, a
biopsy sample was collected. A second treatment cycle, with
intrauterine MV administration at days 5 and 9 post-ovulation,
was performed during the subsequent ovulation (third ovulation
from the first administration). After two consecutive ovulations, a
second biopsy was collected. The histologic analysis showed that
after the first cycle of treatment, the endometritis was classified
as category IIA and it was characterized by a reduction of
inflammatory infiltration with residual microhemorrhages and
edema in the stratum spongiosum (Figure 3A) and occasional
fibrotic glandular nests (Figure 3B).
These features resulted from the previous inflammatory
changes in the endometrium.
Moreover, the histologic analysis of the sample collected
after the second cycle of treatment showed an additional
improvement to I/IIA endometritis. Endometrial biopsy showed
a normal glandular component with residual edema in the
stratum spongiosum (Figure 4A) and some luminal distension
containing eosinophilic material (Figure 4B).
Given the positive improvements in the control biopsies
and at the request of the owner, ovulation was induced with
Buserelin (Receptal, MSD Animal Health, Segrate, Mi, Italy) and
AI was performed using cryopreserved sperm. No inflammatory
fluid retention was observed in the uterine lumen after this
intervention, similarly to what was detected during all the
ultrasound clinical evaluation performed in the past. On the 14th
day after insemination, the first ultrasound check identified an
embryonic vesicle and, thus, the presence of a pregnancy that
is still ongoing (Figure 5). The mare did not develop delayed
uterine clearance after embryo collection or in the past.
DISCUSSION AND CONCLUSIONS
When mesenchymal stromal cells (MSCs) were first used
in regenerative medicine, their therapeutic properties were
attributed to a direct action of differentiation at the site of damage
but it has since been shown that the main mechanism of action
is paracrine signaling (18). This communication occurs via a
cellular secretome that contain soluble factors, such as cytokines,
chemokines, neurotransmitters, and hormones (19), but also
insoluble factors represented by lipid bilayer-delimited particles
called microvesicles (MVs). Literature shows that the beneficial
effects obtained with secretome are equivalent to those obtained
using the cells from which they are derived (16, 20, 21).
In recent years, the regenerative mechanism of MSCs has
been focused on MV action responsible for horizontal transfer of
cytoplasmic content including miRNAs (22). In general, miRNAs
have a key role in cell development, proliferation, differentiation,
apoptosis, and signal transduction (23). In the reproductive
system of mammals, MVs have a key role in follicular growth
and oocyte maturation (24–26). In horses, profiles of MV
miRNAs in follicular fluid vary with age and are associated with
FIGURE 5 | Ultrasound results. They show a 14-day embryo detected after
two cycles of MV administration.
FIGURE 4 | Histological findings of biopsy after the second MV administration. An improvement to I/IIA category endometritis is showed. (A) Normal glandular
component and mild edema in the stratum spongiosum; (B) normal endometrial epithelium. Occasional accumulation of eosinophilic material in a few glands.
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fertility (24, 27). Paracrine signaling between the conceptus and
endometrium is important for fertility and is likely controlled by
miRNAs. A failure in this communication leads to implantation
failure. Day 8 equine embryos are believed to secrete MVs
that can modulate the function of the oviductal epithelium by
the transfer of early pregnancy factors, such as HSP10 and
miRNA (28). MVs, which target biological pathways relevant
for embryo implantation, are also secreted from the endometrial
epithelium (29). This evidence supports our initial hypothesis
about regenerative medicine with MVs, which may be able to
restore both the injured endometrium and re-establish the proper
communication for a successful embryo implantation.
This is the first report discussing the case of a mare affected
by chronic degenerative endometritis and with a history of failed
inseminations, which appeared to have been resolved following
intrauterine administration of MVs secreted in vitro by AMCs.
In this mare, infertility was caused by a defect in the
implantation phase, and not related to conception, as suggested
by the ability to form an 8-day embryo during pre-treatment
tests. The success of the intrauterine administration of MVs was
demonstrated by post-treatment histologic results that showed an
improvement in the classification of endometritis. At the end of
treatment, the mare was classified as almost normal, and 14 day
after AI an embryo was successfully detected by ultrasound and
the pregnancy is still ongoing.
Of course, any of the MVs cargo may have contributed to
an improvement in the pathological picture of this mare, but
our attention has been mainly focused on miRNAs that are
non-coding RNA molecules of about 22 nucleotides in length
that induce gene silencing through translation repression or
degradation of the target molecule (30). In a comparative study
on the miRNA cargo between equine amniotic mesenchymal
cells and their respective MVs, Lange Consiglio et al. (22),
extracted and deeply sequenced small RNAs followed by miRNA
in silico detection. The results showed that there are 146 miRNAs
differentially expressed (DE) between AMCs and MVs. Among
the known DE miRNAs, 17 showed higher expression in MVs
confirming that there is a compartmentalization of miRNAs in
MVs and that the miRNA cargo of MVs is different compared to
that of amniotic origin cells. In addition, this report (22) show
that in amniotic derived MVs there are three specific miRNAs
that have also been studied in other species, and are mainly
involved in modulation of the inflammatory response. These
miRNAs are: miR-223, which inhibits the expression of IL-6, IL-
1b, and TNFα by macrophages (31); miR-150, which decreases
the production of some inflammatory cytokines such as IL-2
and TNFα (32); and miR-126 which promotes angiogenesis and
blocks inflammation of endothelial cells (33).
In the physiopathologic mechanisms of mare endometrosis,
such as in other inflamed tissues, pro-inflammatory cytokines,
growth factors, and chemokines are involved acting on fibroblast
and other cells, and influencing extra-cellular matrix deposition
and tissue fibrosis (34–36). The action of the miRNAs, probably,
was that of down-regulating the expression of pro-inflammatory
molecules, reducing the apoptosis rate, increasing endometrial
cell proliferation, and restoring the anti-inflammatory level
of some cytokines, such as transforming growth factor-β,
as demonstrated in some in vitro studies (17, 37). In this
context, it could therefore be assumed that, in this mare,
the action of MVs and the miRNAs contained in them
induced tissue regeneration with a return to the original
histologic characteristics and, consequently, to the recovery
of normal endometrial function. This probably restored the
conditions that are the basis of maternal-embryonic paracrine
communication, which are necessary for normal development
and implantation.
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